1 Allergen-Specific Immunotherapy for Pediatric Asthma and Rhinoconjunctivitis: A Systematic Review Pediatrics, May 10, 2013 Evidence Based Medicine
2 Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimers disease European Archives of Psychiatry and Clinical Neuroscience, April 19, 2013
3 Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: a cooperative group correlative study Clinical Cancer Research, April 29, 2013
4 Kynurenic Acid in Synovial Fluid and Serum of Patients with Rheumatoid Arthritis, Spondyloarthropathy, and Osteoarthritis The Journal of Rheumatology, April 18, 2013
5 Data shows new Roche leukemia drug may improve on Rituxan Reuters Health News, May 16, 2013
6 Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation rates Respiratory Medicine, April 22, 2013
7 Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults The Journal of Allergy and Clinical Immunology, April 30, 2013
8 Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban Clinical Research in Cardiology, May 14, 2013
9 Selection for axillary clearance in breast cancer (ultrasound negative, sentinel node positive patients have low rates of further metastases) European Journal of Surgical Oncology, May 3, 2013
10 Indicators of Depression and Self-Efficacy in the PPAT Drawings of Normative Adults The Arts in Psychotherapy, May 7, 2013
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor